MCE Molecular Imaging for Myocarditis
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- University of Virginia
- Study ID
- NCT07538544
- Phase
- EARLY_PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Myocarditis Acute
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Myocardial contrast echocardiography molecular imaging for inflammation — DIAGNOSTIC_TESTMyocardial contrast echocardiography (ultrasound of the heart) using an ultrasound contrast agent (Sonazoid, GE Healthcare) that contains phosphatidylserine, thereby targeting it to leukocytes and activated endothelium.
Study Details
Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. Rapid diagnosis of this condition is key to reversing it. The purpose of this study is to determine whether myocarditis such as that which occurs with viral illness, autoimmune conditions, or certain therapies (i.e. immune checkpoint inhibitors) can be diagnosed using a new form of ultrasound imaging of the heart (echocardiography) that uses a contrast agent that is targeted to inflammation (Sonazoid).
Key Dates
- First listed
- Apr 20, 2026
- Start date
- Sep 15, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 30, 2030
- Completion
- Jul 1, 2030
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Patients with suspected MyocarditisPatients with any degree of suspicion for myocarditis based on symptoms, lab tests, ECG, or imaging tests.
Primary Outcome Measure
Diagnostic accuracy for presence/absence of Myocarditis [ Time Frame: 3 months ]
Central Contacts
- Jonathan Lindner, MD14342979442
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22903 |
Find similar trials in Charlottesville, VA
Related Studies
- MYTHS - MYocarditis THerapy With SteroidsPHASE3 · Recruiting · Niguarda Hospital · San Diego, California
- Abatacept in Immune Checkpoint Inhibitor MyocarditisPHASE3 · Recruiting · Massachusetts General Hospital · Los Angeles, California